Trial · NCT01429792
Adverse events51
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 51
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | Pegylated Interferon Alfa 2a (Peginterferon) | 103 | 1,013 | |
| other | Neutropenia | Blood and lymphatic system disorders | Pegylated Interferon Alfa 2a (Peginterferon) | 57 | 1,013 | |
| other | Asthenia | General disorders | Pegylated Interferon Alfa 2a (Peginterferon) | 103 | 1,013 | |
| serious | Anemia | Blood and lymphatic system disorders | Pegylated Interferon Alfa 2a (Peginterferon) | 8 | 1,013 | |
| serious | Haemolytic anemia | Blood and lymphatic system disorders | Pegylated Interferon Alfa 2a (Peginterferon) | 1 | 1,013 | |
| serious | Neutropenic fever | Blood and lymphatic system disorders | Pegylated Interferon Alfa 2a (Peginterferon) | 1 | 1,013 | |
| serious | Pancytopenia | Blood and lymphatic system disorders | Pegylated Interferon Alfa 2a (Peginterferon) | 3 | 1,013 | |
| serious | Acute myocardial infarction | Cardiac disorders | Pegylated Interferon Alfa 2a (Peginterferon) | 2 | 1,013 | |
| serious | Atrial fibrillation | Cardiac disorders | Pegylated Interferon Alfa 2a (Peginterferon) | 1 | 1,013 | |
| serious | Optic nerve disorder | Eye disorders | Pegylated Interferon Alfa 2a (Peginterferon) | 1 | 1,013 | |
| serious | Optic Neuropathy | Eye disorders | Pegylated Interferon Alfa 2a (Peginterferon) | 1 | 1,013 | |
| serious | Retinal haemorrhage | Eye disorders | Pegylated Interferon Alfa 2a (Peginterferon) | 1 | 1,013 | |
| serious | Uveitis | Eye disorders | Pegylated Interferon Alfa 2a (Peginterferon) | 1 | 1,013 | |
| serious | Abdominal pain | Gastrointestinal disorders | Pegylated Interferon Alfa 2a (Peginterferon) | 1 | 1,013 | |
| serious | Abdominal pain lower | Gastrointestinal disorders | Pegylated Interferon Alfa 2a (Peginterferon) | 1 | 1,013 | |
| serious | pancreatitis | Gastrointestinal disorders | Pegylated Interferon Alfa 2a (Peginterferon) | 1 | 1,013 | |
| serious | Pancreatitis acute | Gastrointestinal disorders | Pegylated Interferon Alfa 2a (Peginterferon) | 1 | 1,013 | |
| serious | Vomiting | Gastrointestinal disorders | Pegylated Interferon Alfa 2a (Peginterferon) | 1 | 1,013 | |
| serious | Chest pain | General disorders | Pegylated Interferon Alfa 2a (Peginterferon) | 1 | 1,013 | |
| serious | Oedema Peripheral | General disorders | Pegylated Interferon Alfa 2a (Peginterferon) | 1 | 1,013 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01429792/events